Atara Biotherapeutics (ATRA) EBIT Margin (2021 - 2026)
Atara Biotherapeutics (ATRA) posted EBIT Margin of -749.21% for Q2 2026, down 767.40 percentage points from 18.19% a year earlier and down 96.30 percentage points from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EBIT Margin (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Atara Biotherapeutics was -229.67%, down 233.93 percentage points year-over-year; for FY2025, it came in at 29.69%, up 94.40 percentage points from FY2024.
- Annual EBIT Margin shows a four-year change of +1703.55 percentage points (FY2021 to FY2025).
- In prior years, Atara Biotherapeutics' EBIT Margin was -64.71% in FY2024 (+3154.77 pp), -3219.48% in FY2023 (-2778.42 pp), -441.06% in FY2022 (+1232.80 pp) and -1673.85% in FY2021.
- The Q2 2026 figure stands as the lowest quarterly EBIT Margin since Q4 2023.
- On a year-over-year basis, EBIT Margin has declined in each of the last four quarters, with an average year-over-year change of +397.21 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2023, with a gain of 29049.07 percentage points; the weakest was Q4 2022, with a drop of 29221.82 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -652.91% (Q1 2026), -160.69% (Q4 2025) and -103.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | -749.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -749.21% |
| Mar 31, 2026 | -652.91% |
| Dec 31, 2025 | -160.69% |
| Sep 30, 2025 | -103.50% |
| Jun 30, 2025 | 18.19% |
| Mar 31, 2025 | 39.53% |
| Dec 31, 2024 | -37.26% |
| Sep 30, 2024 | -54.14% |
| Jun 30, 2024 | -63.66% |
| Mar 31, 2024 | -114.22% |
| Dec 31, 2023 | -1,410.21% |
| Sep 30, 2023 | -3,255.94% |
| Jun 30, 2023 | -7,462.28% |
| Mar 31, 2023 | -6,118.92% |
| Dec 31, 2022 | -30,459.27% |
| Sep 30, 2022 | -1,897.78% |
| Jun 30, 2022 | -62.30% |
| Mar 31, 2022 | -1,206.18% |
| Dec 31, 2021 | -1,237.45% |
| Sep 30, 2021 | -1,579.37% |
API Access
Atara Biotherapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();